BSE Live
Nov 26, 16:01Prev. Close
42.95
Open Price
43.36
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 26, 15:55Prev. Close
42.89
Open Price
43.19
Bid Price (Qty.)
44.26 (1354)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Morepen Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.01 | -0.15 | -0.49 | -0.55 | -0.96 | |
| Diluted EPS (Rs.) | 0.01 | -0.15 | -0.49 | -0.55 | -0.96 | |
| Cash EPS (Rs.) | 0.87 | 0.88 | 0.51 | 0.51 | 0.06 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 4.30 | 4.55 | 4.69 | 5.19 | 5.73 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 4.30 | 4.55 | 4.69 | 5.19 | 5.73 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 8.23 | 7.47 | 6.74 | 5.99 | 4.81 | |
| PBDIT/Share (Rs.) | 1.07 | 1.04 | 0.70 | 0.41 | 0.18 | |
| PBIT/Share (Rs.) | 0.21 | 0.02 | -0.31 | -0.63 | -0.83 | |
| PBT/Share (Rs.) | 0.02 | -0.20 | -0.57 | -0.80 | -0.97 | |
| Net Profit/Share (Rs.) | 0.01 | -0.14 | -0.50 | -0.54 | -0.96 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 12.94 | 13.87 | 10.41 | 6.92 | 3.82 | |
| PBIT Margin (%) | 2.52 | 0.24 | -4.66 | -10.47 | -17.33 | |
| PBT Margin (%) | 0.19 | -2.69 | -8.48 | -13.43 | -20.21 | |
| Net Profit Margin (%) | 0.15 | -1.83 | -7.47 | -8.96 | -19.86 | |
| Return on Networth / Equity (%) | 0.29 | -3.01 | -10.75 | -10.34 | -16.68 | |
| Return on Capital Employed (%) | 0.15 | -1.50 | -5.22 | -5.09 | -8.39 | |
| Return on Assets (%) | 0.11 | -1.21 | -4.18 | -4.14 | -6.97 | |
| Total Debt/Equity (X) | 0.33 | 0.37 | 0.45 | 0.49 | 0.50 | |
| Asset Turnover Ratio (%) | 74.02 | 66.15 | 56.02 | 46.24 | 35.12 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.91 | 0.99 | 0.81 | 0.79 | 0.73 | |
| Quick Ratio (X) | 0.60 | 0.66 | 0.47 | 0.44 | 0.41 | |
| Inventory Turnover Ratio (X) | 10.47 | 10.21 | 8.25 | 7.09 | 6.44 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 703.57 | 359.24 | 322.32 | 370.37 | 487.09 | |
| EV/Net Operating Revenue (X) | 1.90 | 1.07 | 1.06 | 1.37 | 2.25 | |
| EV/EBITDA (X) | 14.68 | 7.71 | 10.20 | 19.86 | 58.83 | |
| MarketCap/Net Operating Revenue (X) | 1.43 | 0.51 | 0.37 | 0.52 | 1.11 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 2.73 | 0.84 | 0.54 | 0.60 | 0.94 | |
| Price/Net Operating Revenue | 1.43 | 0.51 | 0.37 | 0.52 | 1.11 | |
| Earnings Yield | 0.00 | -0.04 | -0.20 | -0.17 | -0.18 |
26.11.2025
Morepen Lab Consolidated September 2025 Net Sales at Rs 411.58 crore, down 5.97% Y-o-Y
24.11.2025
Morepen Lab Standalone September 2025 Net Sales at Rs 369.53 crore, down 3.69% Y-o-Y
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y
26.11.2025
Morepen Lab Consolidated September 2025 Net Sales at Rs 411.58 crore, down 5.97% Y-o-Y
24.11.2025
Morepen Lab Standalone September 2025 Net Sales at Rs 369.53 crore, down 3.69% Y-o-Y
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y